Login / Signup

Hormonal treatment for newly diagnosed metastatic prostate cancer: a population-based study from the California cancer registry.

David J BenjaminAnshu ShresthaDimitra FellmanRosemary D CressMark P LythgoeArash Rezazadeh Kalebasty
Published in: Prostate cancer and prostatic diseases (2023)
Despite significant advancements in the treatment of mPC in recent years, over one-fifth of patients did not receive ADT, which is the backbone for all new systemic therapies. This dataset might help address some of the prostate cancer care disparities in California.
Keyphrases